Adipiplon
Adipiplon is a nonbenzodiazepine hypnotic drug that was developed for the treatment of insomnia. It functions as a GABAA receptor agonist, specifically targeting the α3 subunit of the receptor. Adipiplon was designed to provide the sedative effects necessary for sleep induction and maintenance without the side effects commonly associated with benzodiazepines.
Mechanism of Action
Adipiplon works by binding to the GABAA receptor, which is a type of ligand-gated ion channel in the central nervous system. By enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at this receptor, adipiplon increases chloride ion influx into neurons, leading to hyperpolarization and decreased neuronal excitability. This results in a sedative effect, making it easier for individuals to fall asleep and stay asleep.
Pharmacokinetics
The pharmacokinetics of adipiplon involve its absorption, distribution, metabolism, and excretion. After oral administration, adipiplon is rapidly absorbed into the bloodstream. It is metabolized primarily in the liver by the cytochrome P450 enzyme system, particularly CYP3A4. The metabolites are then excreted via the kidneys.
Clinical Trials
Adipiplon has undergone several clinical trials to evaluate its efficacy and safety in treating insomnia. These trials have shown that adipiplon is effective in reducing the time to sleep onset and increasing total sleep time. However, some trials have also reported side effects such as dizziness, headache, and nausea.
Side Effects
Common side effects of adipiplon include:
Less common but more severe side effects may include:
Regulatory Status
As of the latest updates, adipiplon has not been approved by major regulatory agencies such as the Food and Drug Administration (FDA) for clinical use. Further studies are required to fully establish its safety profile and therapeutic efficacy.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
